NCT03102632View on ClinicalTrials.gov

A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Autosomal Dominant Polycystic Kidney
Interventions
OTHER

High Water Intake

After 6 months of usual, unchanged diet and fluid intake, participants will be asked to increase the daily fluid intake based on the principal investigator's prescription. The actual amount of extra water prescribed will depend on the results of the participant's 24 hour urine test.

Trial Locations (1)

10021

The Rogosin Institute, New York

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

lead

The Rogosin Institute

OTHER

NCT03102632 - A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease | Biotech Hunter | Biotech Hunter